TNF and cancer: The mice were divided into two groups: one group was treated with antibiotics prior to the initiation of anti-IL-10 antibody treatment, which is well documented to cause hemorrhagic necrosis in cancer models via upregulating the tumor necrosis factor (TNF), and another group of mice was not treated with antibiotics.